How does market cap make any difference to what the company and its potential is,
Just one of the most popular yardstick for stocks, PE RATIO, there are few more indicators which is very important for clinical stage biotechs, the board, how much are they burning and what are they burning the cash for, can they sustain for another 5 years without additional funding, how advanced are they, what is the demand for their product in market etc etc...if you are just looking at market cap for clinical stage companies, may the God be with you...
IMU
Market Capitalization [ A$1.637 B ]
(/) Net Income [ -A$18.455 M ]
(=) P/E Ratio [ −88.7x ]
RAC
Market Capitalization [ A$446.4 M ]
(/) Net Income [ -A$6.34 M ]
(=) P/E Ratio [ −70.4x ]
Now not much difference isn't it ?
Why IMU is a multi multi bagger, page-6029
-
- There are more pages in this discussion • 19,026 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |